Name Label Description Inactive Type Platform Category TargetFunction LeadContributor Contact Summary Keywords TargetType TargetSubtype Editorial AlternateName Lab LabPI A3R5 NAb A3R5 NAb false ADCC ADCC false ADCC_GTL ADCC_GTL false ADCC_LUC ADCC_LUC false ADCD Antibody-dependent complement deposition false ADCP Antibody-dependent cellular phagocytosis false ADNP Antibody-dependent neutrophil activation/phagocytosis false Ab Avidity Ab Avidity false Anti-Idiotype Binding Antibody Assay Anti-Idiotype Binding Antibody Assay false Anti-idiotype Neutralizing Antibody Assay based on Functional Activity Anti-idiotype Neutralizing Antibody Assay based on Functional Activity false B cell phenotyping B cell phenotyping false B-cell ELISpot B-cell ELISpot false BAMA BAMA false Tomaras Georgia Tomaras BAMA - Saliva BAMA - Saliva false Tomaras Tomaras BCC B Cell Interogation "run by Adrian McDermitt at the VRC Adrian Mc Dermott runs a suite of assays, collectively known as BCC, but individually identified as: BCC-01-Fl (Fluidigm) BCC-02-Ph (Phenotyping) BCC-03-El (ELISPOT) BCC-04-AgCh (antigen characterization) or BCC-04-MSD (general MSD)" false Cytokine MSD Cytokine MSD false MSD McElrath McElrath ELISA ELISA false ELISpot ELISpot false Epitope Mapping Epitope Mapping false Shen/Tomaras Tomaras Fc Array Assay Fc Array Assay false Ackerman Ackerman Glycan Profiling Assay Glycan Profiling Assay false Alter Galit Alter ICS ICS false ICS - 16 color ICS - 16 color false Nicole Frahm IgA_BAMA IgA_BAMA false IgG Subclass BAMA IgG Subclass BAMA Examine IgG1, IgG2, IgG3, and IgG4 binding activity by BAMA. false Tomaras Georgia Tomaras IgG V1V2 IgG V1V2 false IgG and IgA BAMA - Rectal Secretions Mucosal BAMA examines IgG, IgA, and total Ig false Tomaras Tomaras IgG_BAMA IgG_BAMA false NAB NAB false general NAB assay - use when type of assay has not yet been determined Montefiori or Seaman Neutralization of MLV pseudovirus control in ab neutralization assay MLV NAB false Antibody neutralization Neutralizing Antibodies Neutralizing Antibodies false Neutralizing Antibodies, Cohort A Neutralizing Antibodies Ho_PI_310 In Vivo Activity of Ibalizumab Administered by Subcutaneous Injection false Neutralizing Antibodies, Cohort B Neutralizing Antibodies Ho_PI_310 In Vivo Activity of Ibalizumab Administered by Subcutaneous Injection false PK Luminex Pharmacokinetics Measurement via Customized Luminex Assay false Peptide Microarray Peptide Microarray assay run by Shaunna Shen false Pharmacokinetic ELISA Pharmacokinetic ELISA false Pharmacokinetics Measurement via Neutralizing Antibody assay Pharmacokinetics Measurement via Neutralizing Antibody assay false T helper cell evaluation T helper cell evaluation T helper cell evaluation (lymph nodes); this work will be conducted by the CTC VIMC false T26 T cell interogation run by the Koup lab; This name reflects that it is a new flow panel with a target of 26 markers to include Th1, Th2, Th17 as well as the Tfh markers. false TZMbl Nab TZMbl Nab false Tfh and B-cell characterization Tfh and B-cell characterization false bnAb Epitope Mapping bnAb Epitope Mapping The CAVIMC CRL / Nab Core 1 constructed site-directed mutants that eliminate or introduce one or more of the bnAb binding sites into the parental envs of several different viruses. The bnAb will be assayed for the ability to neutralize the parental and mutant viruses, and the reactivity or lack thereof will determine whether this bnAb binds to any of the known bnAb epitopes or to an as yet unmapped epitope. Additional mutants may be constructed to pinpoint the epitope of this novel bnAb. false Montefiori Montefiori cytokine luminex cytokine luminex false mAb screening mAb screening false microarray microarray false mouse IgG-PE BAMA assay mouse IgG-PE BAMA assay false Tomaras Tomaras multiplex gp120/gp160 binding assay multiplex gp120/gp160 binding assay false virus capture virus capture false